1. (a) All office stock shall be labeled with the following information:

   1. (1) Name assigned to the compounded drug preparation.
   2. (2) Name, strength, and quantity of each active ingredient.
   3. (3) Expiration date.
   4. (4) Name or initials of the preparer.
   5. (5) Date of drug preparation.

2. (b) All intravenous (IV), intramuscular (IM), and subcutaneous (SQ) compounded drug preparations for an animal patient that contain a sterile solution shall be labeled with the following information:

   1. (1) Name, strength, and quantity of the ingredient(s) added to the sterile solution.
   2. (2) Date and time of the initial preparation.
   3. (3) Name or initials of the preparer.
3. (c) In addition to the label requirements specified above, all labeling of any dispensed compounded drug preparation shall comply with subsection (b) of section 2032.2.
4. (d) If the label or packaging of a component or ingredient in the compounded drug preparation indicates refrigeration is required, the label of the compounded drug preparation shall state refrigeration is required.

Note: Authority cited: Sections 4808 and 4826.5, Business and Professions Code. Reference: Section 4826.5, Business and Professions Code.

History

1. New section filed 1-4-2022; operative 4-1-2022 (Register 2022, No. 1). (OAL review extended 60 calendar days pursuant to Executive Order N-40-20.)

2. Amendment of section heading, section and Note filed 1-12-2026; operative 4-1-2026 (Register 2026, No. 3).